{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:40:18Z","timestamp":1793662818296,"version":"4.5.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["IGNATO2010"],"award-info":[{"award-number":["IGNATO2010"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nonsense mutations \u2013 the underlying cause of approximately 11% of all genetic diseases \u2013 prematurely terminate protein synthesis by mutating a sense codon to a premature stop or termination codon (PTC). An emerging therapeutic strategy to suppress nonsense defects is to engineer sense-codon decoding tRNAs to readthrough and restore translation at PTCs. However, the readthrough efficiency of the engineered suppressor tRNAs (sup-tRNAs) largely varies in a tissue- and sequence context-dependent manner and has not yet yielded optimal clinical efficacy for many nonsense mutations. Here, we systematically analyze the suppression efficacy at various pathogenic nonsense mutations. We discover that the translation velocity of the sequence upstream of PTCs modulates the sup-tRNA readthrough efficacy. The PTCs most refractory to suppression are embedded in a sequence context translated with an abrupt reversal of the translation speed leading to ribosomal collisions. Moreover, modeling translation velocity using Ribo-seq data can accurately predict the suppression efficacy at PTCs. These results reveal previously unknown molecular signatures contributing to genotype-phenotype relationships and treatment-response heterogeneity, and provide the framework for the development of personalized tRNA-based gene therapies.<\/jats:p>","DOI":"10.1038\/s41467-024-47258-9","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T11:02:07Z","timestamp":1712314927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4068-0325","authenticated-orcid":false,"given":"Nikhil","family":"Bharti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Davyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine","family":"Behrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Eichholtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7351-190X","authenticated-orcid":false,"given":"Alejandro","family":"Jimenez-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2154-0017","authenticated-orcid":false,"given":"Andras","family":"Rab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9341-3354","authenticated-orcid":false,"given":"Eric J.","family":"Sorscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4972-5577","authenticated-orcid":false,"given":"Suki","family":"Albers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9478-8825","authenticated-orcid":false,"given":"Zoya","family":"Ignatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"key":"47258_CR1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/humu.20763","volume":"29","author":"M Mort","year":"2008","unstructured":"Mort, M., Ivanov, D., Cooper, D. N. & Chuzhanova, N. A. A meta-analysis of nonsense mutations causing human genetic disease. Hum. Mut. 29, 1037\u20131047 (2008).","journal-title":"Hum. Mut."},{"key":"47258_CR2","doi-asserted-by":"publisher","first-page":"12508","DOI":"10.1073\/pnas.1605336113","volume":"113","author":"B Roy","year":"2016","unstructured":"Roy, B. et al. Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression. Proc. Natl Acad. Sci. USA 113, 12508\u201312513 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"47258_CR3","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1038\/s41467-021-24575-x","volume":"12","author":"J Sharma","year":"2021","unstructured":"Sharma, J. et al. A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion. Nat. Commun. 12, 4358 (2021).","journal-title":"Nat. Commun."},{"key":"47258_CR4","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.52611","volume":"9","author":"JR Wangen","year":"2020","unstructured":"Wangen, J. R. & Green, R. Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides. eLife 9, e52611 (2020).","journal-title":"eLife"},{"key":"47258_CR5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41586-023-06133-1","volume":"618","author":"S Albers","year":"2023","unstructured":"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842\u2013848 (2023).","journal-title":"Nature"},{"key":"47258_CR6","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/281602a0","volume":"281","author":"JC Chang","year":"1979","unstructured":"Chang, J. C., Temple, G. F., Trecartin, R. F. & Kan, Y. W. Suppression of the nonsense mutation in homozygous beta 0 thalassaemia. Nature 281, 602\u2013603 (1979).","journal-title":"Nature"},{"key":"47258_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41467-019-08329-4","volume":"10","author":"JD Lueck","year":"2019","unstructured":"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019).","journal-title":"Nat. Commun."},{"key":"47258_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/296537a0","volume":"296","author":"GF Temple","year":"1982","unstructured":"Temple, G. F., Dozy, A. M., Roy, K. L. & Kan, Y. W. Construction of a functional human suppressor tRNA gene: an approach to gene therapy for beta-thalassaemia. Nature 296, 537\u2013540 (1982).","journal-title":"Nature"},{"key":"47258_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41586-022-04533-3","volume":"604","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. AAV-delivered suppressor tRNA overcomes a nonsense mutation in mice. Nature 604, 343\u2013348 (2022).","journal-title":"Nature"},{"key":"47258_CR10","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","volume":"390","author":"CM McDonald","year":"2017","unstructured":"McDonald, C. M. et al. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 390, 1489\u20131498 (2017).","journal-title":"Lancet"},{"key":"47258_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.molmed.2023.01.004","volume":"29","author":"S Spelier","year":"2023","unstructured":"Spelier, S., van Doorn, E. P. M., van der Ent, C. K., Beekman, J. M. & Koppens, M. A. J. Readthrough compounds for nonsense mutations: bridging the translational gap. Trends Mol. Med. 29, 297\u2013314 (2023).","journal-title":"Trends Mol. Med."},{"key":"47258_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan, D., Goemans, N., Takeda, S., Mercuri, E. & Aartsma-Rus, A. Duchenne muscular dystrophy. Nat. Rev. Dis. Prim. 7, 13 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"47258_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.743726","volume":"12","author":"J Ding","year":"2021","unstructured":"Ding, J. et al. SCN1A mutation-beyond Dravet syndrome: a systematic review and narrative synthesis. Front. Neurol. 12, 743726 (2021).","journal-title":"Front. Neurol."},{"key":"47258_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0543-7","volume":"11","author":"C Rothblum-Oviatt","year":"2016","unstructured":"Rothblum-Oviatt, C. et al. Ataxia telangiectasia: a review. Orphanet J. Rare Dis. 11, 159 (2016).","journal-title":"Orphanet J. Rare Dis."},{"key":"47258_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","volume":"27","author":"G Veit","year":"2016","unstructured":"Veit, G. et al. From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations. Mol. Biol. Cell 27, 424\u2013433 (2016).","journal-title":"Mol. Biol. Cell"},{"key":"47258_CR16","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1038\/s41467-021-24076-x","volume":"12","author":"S Albers","year":"2021","unstructured":"Albers, S. et al. Repurposing tRNAs for nonsense suppression. Nat. Commun. 12, 3850 (2021).","journal-title":"Nat. Commun."},{"key":"47258_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature14896","volume":"524","author":"A Brown","year":"2015","unstructured":"Brown, A., Shao, S., Murray, J., Hegde, R. S. & Ramakrishnan, V. Structural basis for stop codon recognition in eukaryotes. Nature 524, 493\u2013496 (2015).","journal-title":"Nature"},{"key":"47258_CR18","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.abi7801","volume":"373","author":"MR Lawson","year":"2021","unstructured":"Lawson, M. R. et al. Mechanisms that ensure speed and fidelity in eukaryotic translation termination. Science 373, 876\u2013882 (2021).","journal-title":"Science"},{"key":"47258_CR19","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1093\/nar\/26.22.5017","volume":"26","author":"R Giege","year":"1998","unstructured":"Giege, R., Sissler, M. & Florentz, C. Universal rules and idiosyncratic features in tRNA identity. Nucleic Acids Res. 26, 5017\u20135035 (1998).","journal-title":"Nucleic Acids Res."},{"key":"47258_CR20","doi-asserted-by":"publisher","first-page":"8020","DOI":"10.1093\/nar\/gkw608","volume":"44","author":"H Grosjean","year":"2016","unstructured":"Grosjean, H. & Westhof, E. An integrated, structure- and energy-based view of the genetic code. Nucleic Acids Res. 44, 8020\u20138040 (2016).","journal-title":"Nucleic Acids Res."},{"key":"47258_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cbpa.2018.07.016","volume":"46","author":"OC Uhlenbeck","year":"2018","unstructured":"Uhlenbeck, O. C. & Schrader, J. M. Evolutionary tuning impacts the design of bacterial tRNAs for the incorporation of unnatural amino acids by ribosomes. Curr. Opin. Chem. Biol. 46, 138\u2013145 (2018).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"47258_CR22","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1093\/nar\/gkac222","volume":"50","author":"E Westhof","year":"2022","unstructured":"Westhof, E., Thornlow, B., Chan, P. P. & Lowe, T. M. Eukaryotic tRNA sequences present conserved and amino acid-specific structural signatures. Nucleic Acids Res. 50, 4100\u20134112 (2022).","journal-title":"Nucleic Acids Res."},{"key":"47258_CR23","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1093\/nar\/gkx1315","volume":"46","author":"AG Cridge","year":"2018","unstructured":"Cridge, A. G., Crowe-McAuliffe, C., Mathew, S. F. & Tate, W. P. Eukaryotic translational termination efficiency is influenced by the 3\u2019 nucleotides within the ribosomal mRNA channel. Nucleic Acids Res. 46, 1927\u20131944 (2018).","journal-title":"Nucleic Acids Res."},{"key":"47258_CR24","doi-asserted-by":"publisher","first-page":"e1002608","DOI":"10.1371\/journal.pgen.1002608","volume":"8","author":"C Floquet","year":"2012","unstructured":"Floquet, C., Hatin, I., Rousset, J. P. & Bidou, L. Statistical analysis of readthrough levels for nonsense mutations in mammalian cells reveals a major determinant of response to gentamicin. PLoS Genet. 8, e1002608 (2012).","journal-title":"PLoS Genet."},{"key":"47258_CR25","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/nar\/30.9.2011","volume":"30","author":"L Harrell","year":"2002","unstructured":"Harrell, L., Melcher, U. & Atkins, J. F. Predominance of six different hexanucleotide recoding signals 3\u2019 of read-through stop codons. Nucleic Acids Res. 30, 2011\u20132017 (2002).","journal-title":"Nucleic Acids Res."},{"key":"47258_CR26","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.1073\/pnas.92.12.5431","volume":"92","author":"KK McCaughan","year":"1995","unstructured":"McCaughan, K. K., Brown, C. M., Dalphin, M. E., Berry, M. J. & Tate, W. P. Translational termination efficiency in mammals is influenced by the base following the stop codon. Proc. Natl Acad. Sci. USA 92, 5431\u20135435 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"47258_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/embo-reports\/kve176","volume":"2","author":"O Namy","year":"2001","unstructured":"Namy, O., Hatin, I. & Rousset, J. P. Impact of the six nucleotides downstream of the stop codon on translation termination. EMBO Rep. 2, 787\u2013793 (2001).","journal-title":"EMBO Rep."},{"key":"47258_CR28","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1139\/o95-118","volume":"73","author":"WP Tate","year":"1995","unstructured":"Tate, W. P. et al. Translational termination efficiency in both bacteria and mammals is regulated by the base following the stop codon. Biochem. Cell Biol. 73, 1095\u20131103 (1995).","journal-title":"Biochem. Cell Biol."},{"key":"47258_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/nar\/gkh201","volume":"32","author":"S Tork","year":"2004","unstructured":"Tork, S., Hatin, I., Rousset, J. P. & Fabret, C. The major 5\u2019 determinant in stop codon read-through involves two adjacent adenines. Nucleic Acids Res. 32, 415\u2013421 (2004).","journal-title":"Nucleic Acids Res."},{"key":"47258_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102133","volume":"298","author":"N Biziaev","year":"2022","unstructured":"Biziaev, N. et al. Recognition of 3\u2019 nucleotide context and stop codon readthrough are determined during mRNA translation elongation. J. Biol. Chem. 298, 102133 (2022).","journal-title":"J. Biol. Chem."},{"key":"47258_CR31","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1006\/jmbi.1995.0438","volume":"251","author":"B Bonetti","year":"1995","unstructured":"Bonetti, B., Fu, L., Moon, J. & Bedwell, D. M. The efficiency of translation termination is determined by a synergistic interplay between upstream and downstream sequences in Saccharomyces cerevisiae. J. Mol. Biol. 251, 334\u2013345 (1995).","journal-title":"J. Mol. Biol."},{"key":"47258_CR32","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1371\/journal.pgen.0020221","volume":"2","author":"KA Dittmar","year":"2006","unstructured":"Dittmar, K. A., Goodenbour, J. M. & Pan, T. Tissue-specific differences in human transfer RNA expression. PLoS Genet. 2, e221 (2006).","journal-title":"PLoS Genet."},{"key":"47258_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nrg3861","volume":"16","author":"S Kirchner","year":"2015","unstructured":"Kirchner, S. & Ignatova, Z. Emerging roles of tRNA in adaptive translation, signalling dynamics and disease. Nat. Rev. Genet. 16, 98\u2013112 (2015).","journal-title":"Nat. Rev. Genet."},{"key":"47258_CR34","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1038\/s41467-020-17879-x","volume":"11","author":"O Pinkard","year":"2020","unstructured":"Pinkard, O., McFarland, S., Sweet, T. & Coller, J. Quantitative tRNA-sequencing uncovers metazoan tissue-specific tRNA regulation. Nat. Commun. 11, 4104 (2020).","journal-title":"Nat. Commun."},{"key":"47258_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-cellbio-100617-062754","volume":"34","author":"R Rak","year":"2018","unstructured":"Rak, R., Dahan, O. & Pilpel, Y. Repertoires of tRNAs: the couplers of genomics and proteomics. Annu. Rev. Cell Dev. Biol. 34, 239\u2013264 (2018).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"47258_CR36","doi-asserted-by":"publisher","first-page":"e1006264","DOI":"10.1371\/journal.pgen.1006264","volume":"12","author":"D Sagi","year":"2016","unstructured":"Sagi, D. et al. Tissue- and time-specific expression of otherwise identical tRNA genes. PLoS Genet. 12, e1006264 (2016).","journal-title":"PLoS Genet."},{"key":"47258_CR37","doi-asserted-by":"publisher","first-page":"105089","DOI":"10.1016\/j.jbc.2023.105089","volume":"299","author":"M Davyt","year":"2023","unstructured":"Davyt, M., Bharti, N. & Ignatova, Z. Effect of mRNA\/tRNA mutations on translation speed: implications for human diseases. J. Biol. Chem. 299, 105089 (2023).","journal-title":"J. Biol. Chem."},{"key":"47258_CR38","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2011.10.002","volume":"147","author":"NT Ingolia","year":"2011","unstructured":"Ingolia, N. T., Lareau, L. F. & Weissman, J. S. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147, 789\u2013802 (2011).","journal-title":"Cell"},{"key":"47258_CR39","doi-asserted-by":"publisher","first-page":"e01257","DOI":"10.7554\/eLife.01257","volume":"3","author":"LF Lareau","year":"2014","unstructured":"Lareau, L. F., Hite, D. H., Hogan, G. J. & Brown, P. O. Distinct stages of the translation elongation cycle revealed by sequencing ribosome-protected mRNA fragments. elife 3, e01257 (2014).","journal-title":"elife"},{"key":"47258_CR40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2010612118","volume":"118","author":"R Rauscher","year":"2021","unstructured":"Rauscher, R. et al. Positive epistasis between disease-causing missense mutations and silent polymorphism with effect on mRNA translation velocity. Proc. Natl Acad. Sci. USA 118, e2010612118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"47258_CR41","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1165\/rcmb.2013-0282OC","volume":"50","author":"X Xue","year":"2014","unstructured":"Xue, X. et al. Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor. Am. J. Respir. Cell Mol. Biol. 50, 805\u2013816 (2014).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"47258_CR42","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.molcel.2020.06.010","volume":"79","author":"S Meydan","year":"2020","unstructured":"Meydan, S. & Guydosh, N. R. Disome and trisome profiling reveal genome-wide targets of ribosome quality control. Mol. Cell 79, 588\u2013602.e586 (2020).","journal-title":"Mol. Cell"},{"key":"47258_CR43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022756118","volume":"118","author":"AA Pochopien","year":"2021","unstructured":"Pochopien, A. A. et al. Structure of Gcn1 bound to stalled and colliding 80S ribosomes. Proc. Natl Acad. Sci. USA 118, e2022756118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"47258_CR44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.molcel.2018.08.037","volume":"72","author":"S Juszkiewicz","year":"2018","unstructured":"Juszkiewicz, S. et al. ZNF598 is a quality control sensor of collided ribosomes. Mol. Cell 72, 469\u2013481.e467 (2018).","journal-title":"Mol. Cell"},{"key":"47258_CR45","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2020.06.006","volume":"182","author":"CC Wu","year":"2020","unstructured":"Wu, C. C., Peterson, A., Zinshteyn, B., Regot, S. & Green, R. Ribosome collisions trigger general stress responses to regulate cell fate. Cell 182, 404\u2013416.e414 (2020).","journal-title":"Cell"},{"key":"47258_CR46","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1093\/nar\/gkab194","volume":"49","author":"A Baradaran-Heravi","year":"2021","unstructured":"Baradaran-Heravi, A. et al. Effect of small molecule eRF3 degraders on premature termination codon readthrough. Nucleic Acids Res. 49, 3692\u20133708 (2021).","journal-title":"Nucleic Acids Res."},{"key":"47258_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113056","volume":"42","author":"LA Gurzeler","year":"2023","unstructured":"Gurzeler, L. A. et al. Drug-induced eRF1 degradation promotes readthrough and reveals a new branch of ribosome quality control. Cell Rep. 42, 113056 (2023).","journal-title":"Cell Rep."},{"key":"47258_CR48","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154571","volume":"132","author":"RE Lee","year":"2022","unstructured":"Lee, R. E. et al. Small-molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough. J. Clin. Investig. 132, e154571 (2022).","journal-title":"J. Clin. Investig."},{"key":"47258_CR49","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cell.2009.01.042","volume":"136","author":"N Sonenberg","year":"2009","unstructured":"Sonenberg, N. & Hinnebusch, A. G. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136, 731\u2013745 (2009).","journal-title":"Cell"},{"key":"47258_CR50","doi-asserted-by":"publisher","first-page":"e3000396","DOI":"10.1371\/journal.pbio.3000396","volume":"17","author":"H Park","year":"2019","unstructured":"Park, H. & Subramaniam, A. R. Inverted translational control of eukaryotic gene expression by ribosome collisions. PLoS Biol. 17, e3000396 (2019).","journal-title":"PLoS Biol."},{"key":"47258_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00607-9","volume":"18","author":"P Hao","year":"2020","unstructured":"Hao, P. et al. Eukaryotic translation initiation factors as promising targets in cancer therapy. Cell Commun. Signal 18, 175 (2020).","journal-title":"Cell Commun. Signal"},{"key":"47258_CR52","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fchem.2020.00276","volume":"8","author":"N Laham-Karam","year":"2020","unstructured":"Laham-Karam, N., Pinto, G. P., Poso, A. & Kokkonen, P. Transcription and translation inhibitors in cancer treatment. Front. Chem. 8, 276 (2020).","journal-title":"Front. Chem."},{"key":"47258_CR53","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.32536","volume":"7","author":"LY Chan","year":"2018","unstructured":"Chan, L. Y., Mugler, C. F., Heinrich, S., Vallotton, P. & Weis, K. Non-invasive measurement of mRNA decay reveals translation initiation as the major determinant of mRNA stability. elife 7, e32536 (2018).","journal-title":"elife"},{"key":"47258_CR54","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1016\/j.jmb.2016.05.025","volume":"428","author":"A Radhakrishnan","year":"2016","unstructured":"Radhakrishnan, A. & Green, R. Connections underlying translation and mRNA stability. J. Mol. Biol. 428, 3558\u20133564 (2016).","journal-title":"J. Mol. Biol."},{"key":"47258_CR55","doi-asserted-by":"publisher","first-page":"e1010532","DOI":"10.1371\/journal.pgen.1010532","volume":"18","author":"AMG van den Elzen","year":"2022","unstructured":"van den Elzen, A. M. G., Watson, M. J. & Thoreen, C. C. mRNA 5\u2019 terminal sequences drive 200-fold differences in expression through effects on synthesis, translation and decay. PLoS Genet. 18, e1010532 (2022).","journal-title":"PLoS Genet."},{"key":"47258_CR56","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.jcf.2018.12.001","volume":"18","author":"HC Valley","year":"2019","unstructured":"Valley, H. C. et al. Isogenic cell models of cystic fibrosis-causing variants in natively expressing pulmonary epithelial cells. J. Cyst. Fibros. 18, 476\u2013483 (2019).","journal-title":"J. Cyst. Fibros."},{"key":"47258_CR57","doi-asserted-by":"publisher","first-page":"e2000779","DOI":"10.1371\/journal.pbio.2000779","volume":"15","author":"S Kirchner","year":"2017","unstructured":"Kirchner, S. et al. Alteration of protein function by a silent polymorphism linked to tRNA abundance. PLoS Biol. 15, e2000779 (2017).","journal-title":"PLoS Biol."},{"key":"47258_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"47258_CR59","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-1-0716-1150-0_12","volume":"2252","author":"A Bartholomaus","year":"2021","unstructured":"Bartholomaus, A. & Ignatova, Z. Codon resolution analysis of ribosome profiling data. Methods Mol. Biol. 2252, 251\u2013268 (2021).","journal-title":"Methods Mol. Biol."},{"key":"47258_CR60","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1126\/science.1168978","volume":"324","author":"NT Ingolia","year":"2009","unstructured":"Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. & Weissman, J. S. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 324, 218\u2013223 (2009).","journal-title":"Science"},{"key":"47258_CR61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2016.02.066","volume":"165","author":"NT Ingolia","year":"2016","unstructured":"Ingolia, N. T. Ribosome footprint profiling of translation throughout the genome. Cell 165, 22\u201333 (2016).","journal-title":"Cell"},{"key":"47258_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-1734-7","volume":"16","author":"D Lopez","year":"2015","unstructured":"Lopez, D. & Pazos, F. Protein functional features are reflected in the patterns of mRNA translation speed. BMC Genom. 16, 513 (2015).","journal-title":"BMC Genom."},{"key":"47258_CR63","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1093\/nar\/gkab260","volume":"49","author":"MY Pavlov","year":"2021","unstructured":"Pavlov, M. Y., Ullman, G., Ignatova, Z. & Ehrenberg, M. Estimation of peptide elongation times from ribosome profiling spectra. Nucleic Acids Res. 49, 5124\u20135142 (2021).","journal-title":"Nucleic Acids Res."},{"key":"47258_CR64","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/msb.2013.32","volume":"9","author":"K Bentele","year":"2013","unstructured":"Bentele, K., Saffert, P., Rauscher, R., Ignatova, Z. & Bluthgen, N. Efficient translation initiation dictates codon usage at gene start. Mol. Syst. Biol. 9, 675 (2013).","journal-title":"Mol. Syst. Biol."},{"key":"47258_CR65","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2010.03.031","volume":"141","author":"T Tuller","year":"2010","unstructured":"Tuller, T. et al. An evolutionarily conserved mechanism for controlling the efficiency of protein translation. Cell 141, 344\u2013354 (2010).","journal-title":"Cell"},{"key":"47258_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-019-5864-1","volume":"20","author":"C Polte","year":"2019","unstructured":"Polte, C. et al. Assessing cell-specific effects of genetic variations using tRNA microarrays. BMC Genom. 20, 549 (2019).","journal-title":"BMC Genom."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47258-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47258-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47258-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T12:02:15Z","timestamp":1712318535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-47258-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["47258"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-47258-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]},"assertion":[{"value":"20 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Z.I., S.A., N.B., and M.D. are inventors of patents related to tRNA designs for PTC correction. Z.I. is also a scientific advisor for Tevard Biosciences. E.J.S. is a non-voting trustee for the Cystic Fibrosis Foundation. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2957"}}